Blog
RSS FeedPosted by Michael Wonder on 05 Jun 2023
ICER proposes updates to value assessment framework methods and procedures
5 June 2023 - Proposed updates reflect experience with current framework, benchmarking with other health technology assessment groups, and external stakeholder ...
Posted by Michael Wonder on 13 Apr 2021
New recommendations on the critical appraisal of systematic reviews with cost and cost effectiveness outcomes
13 April 2021 - ISPOR announced today the publication of new guidance on how to evaluate the quality and risk ...
Posted by Michael Wonder on 06 Aug 2020
Principles for deliberative processes in health technology assessment
4 August 2020 - Deliberative processes are a well-established part of health technology assessment programs in a number of high- and ...
Posted by Michael Wonder on 13 Nov 2019
ICER finalises method adaptations for assessing potential cures and other high-impact single or short-term therapies
12 November 2019 - Collaborative project with NICE and CADTH leads to important adaptations for ICER’s methods including creation of optimistic ...
Posted by Michael Wonder on 10 Apr 2018
ICER publishes guidance on improving the development and use of real world evidence for drug coverage and formulary decisions
10 April 2018 - The ICER, in collaboration with the Office of Health Economics, has released two new white papers to ...
Posted by Michael Wonder on 03 Mar 2017
Institute for Clinical and Economic Review publishes white paper on assessment and payment methods for gene therapies
3 March 2017 - Paper presents recommendations for improving evidence generation and assessment methods for gene therapies; also analyses the ...